{"result": "(\"entity\"<|>PACIENTE<|>PERSON<|>A patient is an individual receiving medical treatment, particularly in the context of hematopoietic cell transplantation and nutritional support.)\n##\n(\"entity\"<|>ENFERMEDAD DE INJERTO CONTRA HUÉSPED<|>EVENT<|>Graft-versus-host disease (GVHD) is a condition that can occur after a hematopoietic cell transplantation, where the transplanted cells attack the recipient's body.)\n##\n(\"entity\"<|>CRIBADO NUTRICIONAL<|>EVENT<|>Nutritional screening is a process to identify patients at risk of malnutrition, particularly important for those undergoing hematopoietic cell transplantation.)\n##\n(\"relationship\"<|>PACIENTE<|>TRASPLANTE DE CÉLULAS HEMATOPIÉTICAS<|>Patients undergo hematopoietic cell transplantation as a treatment for various diseases, including cancers<|>9)\n##\n(\"relationship\"<|>PACIENTE<|>ENFERMEDAD DE INJERTO CONTRA HUÉSPED<|>Patients who undergo hematopoietic cell transplantation are at risk of developing graft-versus-host disease<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>CRIBADO NUTRICIONAL<|>Patients undergoing hematopoietic cell transplantation should undergo nutritional screening to assess their nutritional needs<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: , se recomienda evitar el uso de estas sustancias en este tipo de pacientes25.\n\n## 8. Soporte nutricional artificial\n\nCuando el paciente no puede recibir los requerimientos nutricionales con alimentación oral, es preciso plantearse el tratamiento con nutrición artificial. Se ha comprobado un deterioro del estatus nutricional durante el tratamiento antineoplásico en varios estudios prospectivos en los que los pacientes fueron randomizados para recibir NP26 o NE27, versus ausencia de soporte nutricional. En ambos estudios se puso de manifiesto una pérdida de peso significativa en los grupos controles no tratados nutricionalmente.\n\nLa Sociedad Americana de Nutrición Parenteral y Enteral (ASPEN) y la Sociedad Europea de Nutrición Parenteral y Enteral (ESPEN) han establecido guías clínicas en relación con el soporte nutricional de los pacientes sometidos a trasplante de células hematopoyéticas. Sus recomendaciones se resumen en las tablas 5 y 6. La elección de NE o NP en pacientes sometidos a trasplante de células hematopoyéticas se basa más en la experiencia de cada centro, que en resultados objetivos derivados de estudios científicos.\n\n### 8.1. Nutrición enteral\n\nLa nutrición por vía enteral es más fisiológica que por vía parenteral y además ejerce un efecto trófico sobre la mucosa intestinal contribuyendo a su integridad. Se han descrito menos complicaciones, especialmente infecciosas, con NE que con NP en pacientes sometidos a trasplante de células hematopoyéticas28, 29. Si bien existe más tendencia a hemorragia e infección local con NE. Sin embargo, los estudios realizados sobre NE en estos enfermos presentan varios problemas. En primer lugar, han sido realizados predominantemente en población pediátrica, siendo los trabajos en población adulta escasos. Por otro lado, dado que en la mayoría de los estudios realizados la NE se combina con NP y se emplean varios métodos de acceso enteral, los resultados acerca de su superioridad sobre la NP son inciertos. No se han encontrado diferencias estadísticamente sig-\n---\n# Tema 41. Soporte nutricional en el paciente hematológico (trasplante de médula ósea y enfermedad)... 665\n\n## Tabla 5. Guías prácticas sobre el soporte nutricional de los pacientes sometidos a trasplante de células hematológicas según ASPEN (American Society of Parenteral and Enteral Nutrition) (2002).\n\n| | |\n|---|---|\n| A | • La nutrición parenteral deberá ser discontinuada tan pronto como sea posible en estos pacientes.<br>• No se utilizarán rutinariamente dosis farmacológicas de glutamina en pacientes sometidos a trasplante hematológico |\n| B | • Los pacientes sometidos a trasplante de células hematopoyéticas están en riesgo de malnutrición. Todos deben ser sometidos a un cribado nutricional para identificar aquellos que requieren una valoración nutricional y un plan nutricional<br>• Cuando la función gastrointestinal se recupera después del trasplante, se utilizará nutrición enteral en aquellos pacientes cuya ingesta oral es inadecuada, para alcanzar sus requerimientos nutricionales<br>• Los pacientes recibirán consejo dietético en relación con la manipulación e ingesta de alimentos para evitar el riesgo de infección durante la etapa de inmunosupresión |\n| C | • El soporte nutricional artificial es apropiado en pacientes sometidos a trasplante de células hematopoyéticas que desarrollen la enfermedad de injerto contra huésped moderada-severa con ingesta oral insuficiente |\n\n## Tabla 6. Guías prácticas sobre el soporte nutricional de los pacientes sometidos a trasplante de células hematológicas según la ESPEN (European Society of Parenteral and Enteral Nutrition) (2006).\n\n| | |\n|---|---|\n| A | - |\n| B | - |\n| C | • El uso rutinario de nutrición enteral no está indicado<br>• Si la ingesta oral está disminuida, la nutrición parenteral es preferible a la nutrición enteral por sonda en presencia de infección o hemorragia en pacientes inmunodeprimidos o con trombopenia<br>• La administración enteral de glutamina o EPA no se recomienda, debido a que no existen datos concluyentes de su beneficio |\n\nnificativas con respecto a la NP en cuanto a la recuperación de los parámetros hematológicos y la supervivencia30-32. En contraste, la NE se asocia a menor frecuencia de colestasis33, menor incidencia de hemocultivos positivos, menor tasa de muerte por infección precoz en los primeros 100 días después del trasplante34, menor incidencia de EICH34, menor duración de la diarrea30 y de la estancia hospitalaria35, 36 y menor coste nutricional medio por paciente32, 33. En cuanto al mantenimiento del\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>SOCIEDAD AMERICANA DE NUTRICIÓN PARENTERAL Y ENTERAL<|>ORGANIZATION<|>ASPEN is an organization that establishes clinical guidelines for nutritional support in patients undergoing hematopoietic cell transplantation.)\n##\n(\"entity\"<|>SOCIEDAD EUROPEA DE NUTRICIÓN PARENTERAL Y ENTERAL<|>ORGANIZATION<|>ESPEN is an organization that provides clinical guidelines for nutritional support in patients undergoing hematopoietic cell transplantation.)\n##\n(\"entity\"<|>TRASPLANTE DE CÉLULAS HEMATOPIÉTICAS<|>EVENT<|>Hematopoietic cell transplantation is a medical procedure where stem cells are transplanted to replace damaged or diseased bone marrow.)\n##\n(\"entity\"<|>NUTRICIÓN ENTERAL<|>EVENT<|>Enteral nutrition is a method of delivering nutrients directly into the gastrointestinal tract, which is more physiological than parenteral nutrition.)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL<|>EVENT<|>Parenteral nutrition is a method of providing nutrients intravenously, bypassing the gastrointestinal tract, often used when patients cannot eat.)\n##\n(\"relationship\"<|>SOCIEDAD AMERICANA DE NUTRICIÓN PARENTERAL Y ENTERAL<|>TRASPLANTE DE CÉLULAS HEMATOPIÉTICAS<|>ASPEN provides clinical guidelines for nutritional support specifically for patients undergoing hematopoietic cell transplantation<|>8)\n##\n(\"relationship\"<|>SOCIEDAD EUROPEA DE NUTRICIÓN PARENTERAL Y ENTERAL<|>TRASPLANTE DE CÉLULAS HEMATOPIÉTICAS<|>ESPEN offers clinical guidelines for nutritional support in patients undergoing hematopoietic cell transplantation<|>8)\n##\n(\"relationship\"<|>NUTRICIÓN ENTERAL<|>TRASPLANTE DE CÉLULAS HEMATOPIÉTICAS<|>Enteral nutrition is recommended for patients recovering from hematopoietic cell transplantation when oral intake is inadequate<|>7)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>TRASPLANTE DE CÉLULAS HEMATOPIÉTICAS<|>Parenteral nutrition is used when patients undergoing hematopoietic cell transplantation cannot meet their nutritional needs orally<|>7)\n<|COMPLETE|>"}]}